Half-year report on the liquidity contract between Safe Orthopaedics and Louis Capital Markets

Nachrichtenquelle: globenewswire
30.07.2020, 18:00  |  113   |   |   

Eragny-sur-Oise, France, July 30, 2020 – 18h00 CEST – Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, is today releasing its half-year report on the liquidity contract signed with Louis Capital Markets on June 1, 2018.

 The liquidity account had the following holdings as of June 30, 2020:

  • 1 012 shares
  • 364,57 euros

During the first half of 2020, the following have been negotiated:

PURCHASE 72 138 shares 9 771,00 euros 547 transactions
SALE 230 545 shares 9 894,38 euros 507 transactions


For the prior period (December 31, 2019), the corresponding figures were:

  • 159 419 shares
  • 1 623,33 euros

As of March 18, 2019 (implementation of the new liquidity contract), the followings were made available:

  • 74 738 shares
  • 7 561,33 euros

The detail of day-to-day activities is as follows:

  Purchase Sale
ALSAF FP Trading volume Number of shares Cash (EUR) Trading volume Number of shares Cash (EUR)
Total 547 72 138 9 771,00 507 230 545 9 894,38
20200101 0 0 0,00 0 0 0,00
20200102 2 4 391 39,52 1 1 0,01
20200103 2 3 891 32,69 1 1 0,01
20200106 1 1 0,01 1 1 0,01
20200107 1 1 0,01 11 38 511 401,57
20200108 10 37 031 437,66 2 2 851 38,77
20200109 2 2 981 32,79 2 4 871 58,45
20200110 1 1 0,01 2 4 821 57,85
20200113 1 1 0,01 11 35 411 478,84
20200114 1 1 0,02 11 27 411 434,21
20200115 5 15 491 240,57 7 15 771 280,75
20200116 1 1 0,02 2 1 961 34,51
20200117 1 610 1 604,30 1 91 599 1 602,98
20200120 9 172 391,58 4 33 80,45
20200121 11 183 391,24 1 1 2,30
20200122 6 85 159,97 2 21 41,57
20200123 8 118 203,93 2 31 57,44
20200124 1 1 1,80 11 230 418,10
20200127 6 94 169,59 2 21 39,89
20200128 4 58 98,89 5 88 161,02
20200129 6 96 160,69 4 71 125,62
20200130 6 96 155,51 2 21 35,70
20200131 4 58 93,22 5 88 147,89
20200203 5 76 122,44 2 21 35,14
20200204 1 1 1,64 4 81 132,76
20200205 4 60 93,19 3 41 65,84
20200206 5 78 122,04 2 21 34,23
20200207 3 38 58,66 4 81 131,22
20200210 4 60 90,85 2 21 32,65
20200211 5 78 115,20 1 1 1,50
20200212 4 61 87,87 9 201 309,91
20200213 6 111 168,65 2 21 33,60
20200214 5 81 119,80 1 1 1,50
20200217 6 101 145,54 1 1 1,50
20200218 6 99 134,36 2 31 44,33
20200219 4 59 79,65 5 111 158,92
20200220 5 80 108,29 5 111 163,17
20200221 5 80 105,69 1 1 1,36
20200224 11 215 250,70 1 1 1,28
20200225 5 159 183,77 5 141 169,99
20200226 5 70 80,48 2 41 49,20
20200227 5 203 226,77 3 71 83,64
20200228 6 72 78,59 1 1 1,11
20200302 4 49 49,70 7 221 243,52
20200303 3 24 24,32 4 109 114,45
20200304 4 51 50,72 1 1 1,03
20200305 8 137 124,96 1 1 0,96
20200306 6 79 66,02 1 1 0,87
20200309 1 1 0,78 1 1 0,78
20200310 5 76 53,94 2 51 37,59
20200311 3 170 119,98 8 531 391,42
20200312 8 144 98,22 6 157 125,57
20200313 5 86 55,55 2 31 20,97
20200316 10 236 141,21 5 90 60,78
20200317 4 44 24,96 6 94 57,73
20200318 9 101 55,75 5 74 49,72
20200319 7 178 106,56 9 208 137,28
20200320 6 50 29,00 4 371 229,34
20200323 4 34 20,40 4 50 31,45
20200324 1 1 0,66 10 154 101,02
20200325 4 50 30,80 2 2 1,29
20200326 3 33 19,49 4 48 30,91
20200327 3 33 19,28 3 20 12,20
20200330 2 21 12,20 4 48 28,93
20200331 4 51 29,24 2 23 13,49
20200401 1 1 0,59 11 154 94,19
20200402 11 106 88,69 3 37 34,86
20200403 5 60 42,09 3 45 33,89
20200406 3 24 16,79 15 309 230,75
20200407 4 36 25,79 3 29 21,62
20200408 4 36 25,19 4 36 27,00
20200409 3 31 21,01 4 36 25,92
20200410 0 0 0,00 0 0 0,00
20200413 0 0 0,00 0 0 0,00
20200414 4 44 29,73 1 1 0,70
20200415 3 29 19,54 11 115 84,96
20200416 1 1 0,72 11 106 77,19
20200417 6 64 50,96 10 84 75,14
20200420 4 38 28,74 1 1 0,77
20200421 4 39 27,59 1 1 0,73
20200422 2 21 14,35 4 31 21,95
20200423 3 34 23,83 2 12 8,71
20200424 2 18 12,35 3 27 19,10
20200427 4 39 26,45 1 1 0,68
20200428 3 31 21,03 4 33 23,33
20200429 3 31 21,35 4 33 23,78
20200430 4 48 33,01 1 1 0,71
20200501 0 0 0,00 0 0 0,00
20200504 6 83 56,02 1 1 0,68
20200505 3 28 18,96 2 17 12,03
20200506 4 53 35,48 1 1 0,69
20200507 1 1 0,68 11 131 96,28
20200508 4 31 21,37 3 23 16,51
20200511 4 32 21,69 2 16 11,20
20200512 9 108 68,11 1 1 0,67
20200513 3 25 15,43 11 130 89,35
20200514 9 115 67,75 4 31 20,65
20200515 3 27 15,52 3 27 16,13
20200518 4 35 19,93 2 18 10,61
20200519 4 33 19,21 1 1 0,60
20200520 4 32 18,29 1 1 0,58
20200521 4 32 18,22 2 20 11,77
20200522 4 32 17,97 2 20 11,62
20200525 3 25 13,82 4 39 22,52
20200526 1 1 0,57 6 68 40,60
20200527 4 32 19,19 3 28 17,57
20200528 4 30 17,98 2 15 9,33
20200529 4 32 19,21 1 1 0,62
20200601 1 1 0,61 10 128 81,10
20200602 1 1 0,67 9 145 101,32
20200603 11 257 165,81 4 53 37,10
20200604 5 91 55,03 4 57 35,50
20200605 5 121 71,17 2 11 6,69
20200608 5 81 46,77 2 31 18,38
20200609 1 1 0,60 10 217 134,12
20200610 5 101 60,08 6 97 60,36
20200611 5 111 65,15 4 56 34,13
20200612 2 31 17,68 8 139 82,75
20200615 1 1 0,57 4 56 32,60
20200616 4 91 52,07 2 21 12,31
20200617 4 91 51,66 10 161 99,46
20200618 9 203 110,33 1 1 0,57
20200619 6 137 73,08 1 1 0,54
20200622 5 81 42,07 5 111 60,02
20200623 5 87 44,50 3 33 17,59
20200624 1 1 0,54 9 199 108,77
20200625 5 81 43,48 4 58 32,42
20200626 8 122 63,09 5 78 42,45
20200629 4 59 29,88 6 109 57,63
20200630 5 77 39,07 1 1 0,51

Next financial release:

First semester 2020 results, September 28th, 2020 (post-market)

About Safe Orthopaedics

Founded in 2010, Safe Orthopaedics is a French medical technology company, a pioneer of the design and marketing of innovative ready-to-use technologies (single-use implants and instruments) for spinal diseases, delivering the safest treatment of spinal fractures. The technologies include sterile implants and ready-to-use instruments available to the surgeon at any time and anywhere, enabling minimally invasive approaches, reducing the risks of cross contamination and infection in the interest of the patient. Protected by 17 patent families, the SteriSpineTM Kits are CE marked, FDA and CFDA approved. Safe Orthopaedics, has its headquarter close to Paris (95610 Eragny-Sur-Oise - France) and has created a subsidiary in the UK, Germany and in the US, employing around 50 employees for a total sales of 4.7M€ in 2019. For more information : www.SafeOrthopaedics.com


Contacts 

Safe Orthopaedics                                                                                                             
François-Henri Reynaud                                                                 
Chief Financial Officer                    
Tél. : +33 (0)1 34 21 50 00                                           
investors@safeorthopaedics.com               

Press Relations
Ulysse Communication
Bruno Arabian / +33 (0)6 87 88 47 26 / barabian@ulysse-communication.com
Nicolas Daniels / +33 (0)6 63 66 59 22 / ndaniels@ulysse-communication.com

Attachment


Safe Orthopaedics Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de



Diesen Artikel teilen

0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Half-year report on the liquidity contract between Safe Orthopaedics and Louis Capital Markets Eragny-sur-Oise, France, July 30, 2020 – 18h00 CEST – Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures …

Meistgelesene Nachrichten des Autors

Titel
Titel
Titel
Titel